人物介紹
謝幸 ,男,1955年7月生,主任醫師,教授,院長,博士生導師。1983年畢業於浙江大學醫學院(原浙江醫科大學)。曾先後留學德國、美國等國。現任浙江大學醫學院附屬婦產科醫院院長、浙江大學婦產科學研究所所長、浙江省重點學科——婦產科學學科帶頭人。一直從事婦產科臨床、科研及教學工作,主要方向為婦科腫瘤臨床與基礎研究;主持或參加國家自然科學基金等國家、省部級項目數10項;獲省部級科技進步獎4項;近年在國內外各類期刊發表論著100餘篇,其中SCI源期刊論文近20篇,相關學術論文多次被國內外學者在重要學術期刊引用。分別擔任衛生部規劃教材五年制《婦產科學》第六版副主編、衛生部規劃教材七年制及長學制《婦產科學》編委和衛生部專升本《婦產科學》主編。先後共培養博士後1名、博士10餘名和碩士30餘名。
學術兼職
中華醫學會婦產科學分會常委
中華醫學會婦科腫瘤學分會常委
中華預防醫學會婦女保健學會常委
中國抗癌協會婦科腫瘤專業委員會委員
浙江醫學會婦產科學分會主任委員
浙江抗癌協會婦科腫瘤專業委員會主任委員
中華醫學雜誌編委
中華婦產科雜誌編委
中華全科醫師雜誌編委
現代婦產科進展常務編委
中國實用婦科與產科雜誌常務編委
實用婦產科雜誌常務編委
實用腫瘤雜誌常務編委
國外醫學(婦產科學分冊)副主編。
研究方向
1. 卵巢癌與腹腔免疫缺陷及其機制
2. 宮頸癌發生的免疫學和分子遺傳學機制
3. 妊娠滋養細胞疾病發病的分子遺傳學機制
發表的SCI文獻
(1)Interleukin-7 and Suppression of Local Peritoneal Immunity in Ovarian Carcinoma. Int J Gynecol Obstet 2004;85:151-158. (通訊作者)
(2)Effect of Interleukin-7 Gene Transfection into Ovarian Carcinoma Cell Line SKOV3 In vitro and In vivo. Gynocol Oncol 2004;92(2):578-585. (通訊作者)
(3)Ovarian cacinoma cells inhibit T cell proliferation: suppression of IL-12 receptor β and γ expression and their JAK-STAT signaling. Life Science 2004;74(14): 1739-1749. (通訊作者)
(4)VEGF And Ovarian Cancer Cell Supernatant Activate Signal Transducers And Activators Of Transcription (STATs) Via VEGF Receptor-2 (KDR) In Human Hemopoietic Progenitor Cells. Gynocol Oncol 2004;94:125-133(通訊作者)
(5)VEGF,VEGFRs expressions and activated STATs in ovarian epithelial carcinoma. Gynecol Oncol,2004;94:630-635(通訊作者)
(6)Impaired mixed lymphocyte reaction in intrahepatic cholestasis of pregnancy. Gynecol Obstet Invest,2002:54:191-195
(7)Sedentary behaviours and epithelial ovarian cancer risk. Cancer Causes and Control,2004;15:83-89(8)The value of curettage in diagnosis of endometrial hyperplasia. Gynecol Oncol. 2002;84(1):135-139. (通訊作者)
(9)Lack of mutation in tumor-suppressor gene p53 in gestational trophoblastic tumours. Br J Cancer 1996;73:1216-1219.
(10)Cell culture of biopsied endometriomas after danazol/hormonal therapy:A study of growth features and fertility effects. Indian J Exper Bio.2000;38:1192-1200.
(11)Ovarian Carcinoma Cells Effectively Inhibit Differentiation And Maturation Of Dendritic Cells Derived From Hematopoietic Progenitor Cells In Vitro. Cancer Investigation, in printing. (通訊作者)
(12) Mismatch repair gene promoter methylation and expression in hydatidiform moles. Arch Gynecol Obstet. 2005;272:35-39; (通訊作者)
(13) PTEN Promoter Methylation and Protein Expression in Normal Early Placentas and Hydatidiform Moles. J Soc Gynecol Investig 2005;12:214 –7
(14) Proportion of CD4+CD25+ regulatory T cell is increased in the paitients with ovarian cancer. Cancer Investigation. 2005, in printing. (通訊作者)
(15)Growth inhibition of interleukin-2 receptor gene-tranduced peripheral blood lymphocytes on human ovarian cancer cells. Chin Med J, 2001; 114 (3): 303-307.